A California jury ruled in favor of Masimo, a medical tech company, in its patent infringement case against Apple, claiming the tech giant violated a patent related to blood-oxygen monitoring technology used in the Apple Watch. Apple plans to appeal, arguing the patent expired in 2022 and pertains to outdated technology. This lawsuit is part of a broader conflict, as Masimo has accused Apple of infringing multiple patents, leading to temporary sales halts of certain smartwatches. Masimo has also challenged the US Customs and Border Protection for allowing updated Apple Watches to be sold without its approval.
Want More Context? 🔎
Loading PerspectiveSplit analysis...
